D-Pantothenic acid
(Synonyms: D-泛酸; Pantothenate; Vitamin B5) 目录号 : GC17311
A precursor in the biosynthesis of coenzyme A
Cas No.:79-83-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
D-Pantothenic acid (vitamin B5) is a water-soluble vitamin and is an essential nutrient to synthesize coenzyme-A, fats, proteins and carbohydrates.
D-Pantothenic acid is a water-soluble vitamin. In rabbits, pentothenate (20 mg/kg) significantly increased aponeurosis strength after surgery and improved the strength of the skin. Also, pentothenate significantly increased the fibroblast content of the scar during the fibroblast proliferation phase [1]. Pantothenic acid deficiency increased occurrence of hypertension due to adrenal regeneration [2]. In rabbits, cerebellar and forebrain slices were able to accumulate and phosphorylate pantothenic acid. However, medium-chain fatty acids, probenecid and ouabain inhibited pantothenic acid accumulation by forebrain slices and inhibited conversion to CoA [3]. In ICR mice, pantothenic acid significantly reduced valproic acid (VPA)-induced exencephaly, which suggested that pantothenic acid inhibited neural tube defects induced by VPA [4].
References:
[1]. Aprahamian M, Dentinger A, Stock-Damgé C, et al. Effects of supplemental pantothenic acid on wound healing: experimental study in rabbit. Am J Clin Nutr, 1985, 41(3): 578-589.
[2]. Schwabedal PE, Pietrzik K, Wittkowski W. Pantothenic acid deficiency as a factor contributing to the development of hypertension. Cardiology, 1985, 72 Suppl 1: 187-189.
[3]. Spector R. Development and characterization of pantothenic acid transport in brain. J Neurochem, 1986, 47(2): 563-568.
[4]. Sato M, Shirota M, Nagao T. Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I). Teratology, 1995, 52(3): 143-148.
| Cas No. | 79-83-4 | SDF | |
| 别名 | D-泛酸; Pantothenate; Vitamin B5 | ||
| 化学名 | 3-[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoic acid | ||
| Canonical SMILES | CC(C)(CO)C(C(=O)NCCC(=O)O)O | ||
| 分子式 | C9H17NO5 | 分子量 | 219.23954 |
| 溶解度 | ≥ 11.15mg/mL in DMSO with gentle warming | 储存条件 | Store at -20°C |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 4.5612 mL | 22.8061 mL | 45.6122 mL |
| 5 mM | 0.9122 mL | 4.5612 mL | 9.1224 mL |
| 10 mM | 0.4561 mL | 2.2806 mL | 4.5612 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet